The Desk

AI-assisted analysis on every release · Page 48

Production / Operations
Adamera consolidates its Washington tungsten hub ahead of a 2027 U.S. defense deadline to secure critical supply chains.

Jun 25, 2026 · 09:01 · ADZ · Adamera Minerals Corp. · Routine +

01
Other
Brand extension marketing adds zero near-term financial weight to a stock already discounting tariff headwinds and a sluggish Melissa & Doug turnaround.

Jun 25, 2026 · 09:00 · TOY · SPIN MASTER CORP. SV · Routine +

02
Drill Results
Fox Tungsten launches a 20,000m drill campaign at its Fox Project to support a 2027 preliminary economic assessment.

Jun 25, 2026 · 09:00 · FOXT · Fox Tungsten Ltd. · Routine +

03
Drill Results
Metals Creek’s High-Grade Ogden drill hit validates the structural model despite narrow width and going concern risks tempering near-term upside.

Jun 25, 2026 · 08:31 · MEK · Metals Creek Resources Corp. · Routine +

04
Other
Next-gen millimeter-wave screening for aviation and critical infrastructure, post-IPO scaling phase.

Jun 25, 2026 · 08:30 · SCAN · Liberty Defense Holdings, Ltd. · Routine +

05
Other
Preclinical PNKP inhibitor developer burns cash and raises capital while marketing AI oncology partnerships to a niche market.

Jun 25, 2026 · 08:30 · ONCO · ONCO-INNOVATIONS LIMITED · Neutral

06
Other
Pre-revenue MS developer navigates FDA clinical hold while doubling down on myelin-repair narrative and consumer-health royalties

Jun 25, 2026 · 08:30 · QNTM · Quantum BioPharma Ltd. · Neutral

07
Drill Results
Early-stage polymetallic explorer advancing Green Monster and Wildhorse projects in Nevada amid lower-than-expected assay grades.

Jun 25, 2026 · 08:30 · GSTR · Glenstar Minerals Inc. · Routine +

08
Other
Israeli med-tech SaaS expands domestic footprint while navigating severe liquidity constraints and unproven U.S. commercialization.

Jun 25, 2026 · 08:30 · SEGN · Seegnal Inc. · Routine +

09
M&A / Property
Campus safety partnership validates commercial diversification, but margin compression and heavy SG&A burn keep the stock in a consolidation phase.

Jun 25, 2026 · 08:30 · DPRO · Draganfly Inc. · Routine +

10
Drill Results
High-grade gold intercepts at Cole confirm continuity below historic workings, but cash burn and going concern risks persist.

Jun 25, 2026 · 08:30 · RKL · Rockland Resources Ltd. · Routine +

11
Technical Study
Anfield completes Phase I at Velvet-Wood and updates its PEA, confirming robust economics for its hub-and-spoke uranium-vanadium strategy.

Jun 25, 2026 · 08:17 · AEC · Anfield Energy Inc. · Routine +

12
Other
Regulatory clearance unlocks 2026 drilling campaign at Silver Vista, but exploration risk remains unmitigated until assay data validates the district-scale thesis.

Jun 25, 2026 · 08:11 · MAV · Maverick Gold and Silver Corporation · Routine +

13
M&A / Property
Falcon expands the Atikokan footprint with the West Hammond contact option despite ongoing liquidity constraints.

Jun 25, 2026 · 08:02 · FG · Falcon Gold Corp. · Routine +

14
Drill Results
Bold Ventures reported high-grade gold at Traxxin, though short intervals and dilution limit the potential upside of the discovery.

Jun 25, 2026 · 08:02 · BOL · Bold Ventures Inc. · Routine +

15

← Newer Older →

The Desk

Adamera consolidates its Washington tungsten hub ahead of a 2027 U.S. defense deadline to secure critical supply chains.

Brand extension marketing adds zero near-term financial weight to a stock already discounting tariff headwinds and a sluggish Melissa & Doug turnaround.

Fox Tungsten launches a 20,000m drill campaign at its Fox Project to support a 2027 preliminary economic assessment.

Metals Creek’s High-Grade Ogden drill hit validates the structural model despite narrow width and going concern risks tempering near-term upside.

Next-gen millimeter-wave screening for aviation and critical infrastructure, post-IPO scaling phase.

Preclinical PNKP inhibitor developer burns cash and raises capital while marketing AI oncology partnerships to a niche market.

Pre-revenue MS developer navigates FDA clinical hold while doubling down on myelin-repair narrative and consumer-health royalties

Early-stage polymetallic explorer advancing Green Monster and Wildhorse projects in Nevada amid lower-than-expected assay grades.

Israeli med-tech SaaS expands domestic footprint while navigating severe liquidity constraints and unproven U.S. commercialization.

Campus safety partnership validates commercial diversification, but margin compression and heavy SG&A burn keep the stock in a consolidation phase.

High-grade gold intercepts at Cole confirm continuity below historic workings, but cash burn and going concern risks persist.

Anfield completes Phase I at Velvet-Wood and updates its PEA, confirming robust economics for its hub-and-spoke uranium-vanadium strategy.

Regulatory clearance unlocks 2026 drilling campaign at Silver Vista, but exploration risk remains unmitigated until assay data validates the district-scale thesis.

Falcon expands the Atikokan footprint with the West Hammond contact option despite ongoing liquidity constraints.

Bold Ventures reported high-grade gold at Traxxin, though short intervals and dilution limit the potential upside of the discovery.